Lorediplon
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
N-{2-fluoro-5-[3-(thiophen-2-ylcarbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl}-N-methylacetamide | |
| Clinical data | |
| Legal status |
|
| Identifiers | |
| CAS Number |
917393-39-6 |
| ATC code | None |
| PubChem | CID 12004146 |
| ChemSpider |
10176613 |
| Chemical data | |
| Formula | C20H15FN4O2S |
| Molar mass | 394.422 g/mol |
| |
| |
| (verify) | |
Lorediplon (INN) is a nonbenzodiazepine of the pyrazolopyrimidine family that is being pursued as a treatment for insomnia but has not completed development.[1]
References
- ↑ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN): Proposed INN: List 105" (PDF). WHO Drug Information 25 (2): 179.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
